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SUMMARY
This study examined the prevalence of the intestinal spirochaetes Brachyspira aalborgi and
Brachyspira pilosicoli in diﬀerent Western Australian (WA) populations. Faecal samples included
287 from rural patients with gastrointestinal symptoms, comprising 142 from non-Aboriginal and
145 from Aboriginal people; 227 from recent healthy migrants to WA from developing countries;
and 90 from healthy non-Aboriginal individuals living in Perth, WA. DNA was extracted from
faeces, and subjected to PCR assays for both species. B. pilosicoli-positive individuals were
conﬁned to the rural Aboriginal (14.5%) and migrant (15.0%) groups. B. aalborgi was detected
at a lower but similar prevalence in all four groups: rural non-Aboriginals, 5.6%; rural
Aboriginals, 6.9%; migrants, 7.9%; controls, 5.6%. In migrants and Aborigines, the presence
of B. pilosicoli and B. aalborgi was associated (P<0.001), suggesting that colonization by
B. pilosicoli may be facilitated by colonization with B. aalborgi. Amongst the Aboriginal patients,
logistic regression identiﬁed both spirochaete species as being associated with chronic diarrhoea,
failure to thrive and being underweight. Both species may have pathogenic potential, but
B. aalborgi appears more host-adapted than the opportunistic B. pilosicoli.
INTRODUCTION
Brachyspira aalborgi and Brachyspira pilosicoli are
related anaerobic intestinal spirochaetes that colonize
human beings [1]. Both species can attach by one
cell end to the lumenal surface of the colorectal epi-
thelium. Large numbers of attached spirochaetes may
form a ‘false brush border’, and this histologically
deﬁned condition is known as ‘intestinal spirochae-
tosis’ (IS) [2]. In colorectal biopsies with IS from the
general population in developed countries, B. aalborgi
is more commonly present than B. pilosicoli [3, 4].
B. aalborgi is diﬃcult to culture due to its fastidious
growth requirements and extremely slow growth rate.
It is usually detected by polymerase chain reaction
(PCR) or gene probe assays, and has only occasion-
ally been isolated [5–7]. B. pilosicoli is easier to
isolate, and has been cultured from faeces in several
developing countries [8–11], from Australian Abori-
gines [12, 13], migrants to Australia from developing
countries [13] and homosexual males [14]. Prevalence
rates for B. pilosicoli in the faeces of these populations
vary from y10 to 50%. It is rarely identiﬁed in other
populations [12, 15]. B. pilosicoli also colonizes many
animal species, and is a well-recognized pathogen of
pigs and poultry [16, 17].
Compared to B. pilosicoli, there is limited under-
standing of the distribution of B. aalborgi. Most
studies on B. aalborgi have focussed on its detection
in intestinal biopsies. One recent large-scale study
* Author for correspondence: Dr D. J. Hampson, School of
Veterinary and Biomedical Sciences, Murdoch University,
Murdoch, WA 6150, Australia.
(Email: d.hampson@murdoch.edu.au)
Epidemiol. Infect. (2006), 134, 627–634. f 2005 Cambridge University Press
doi:10.1017/S0950268805005170 Printed in the United Kingdomexamined its presence in faecal specimens [11]; PCR
was used on DNA extracted from faeces to investigate
carriage of both spirochaete species amongst workers
on tea plantations in Assam, India. The prevalence
of B. aalborgi (6%) was considerably less than for
B. pilosicoli (25%). In a study of Dutch patients with
chronic diarrhoea of unknown aetiology, B. pilosicoli
was not detected using faecal PCR, whilst two of
182 samples (1.1%) were positive for B. aalborgi [18].
Currently, the impact on human health caused by
colonization with intestinal spirochaetes remains
unclear [1].
The purpose of our study was to record and
compare the prevalence of B. pilosicoli and B. aalborgi
in diﬀerent population groups in Western Australia
(WA). We used speciﬁc PCRs for the two species on
DNA extracted from faeces. Most samples previously
had been investigated for B. pilosicoli by culture [13].
This allowed additional comparison of the usefulness
of faecal culture compared to PCR for detection of
B. pilosicoli, and helped ensure the quality control on
the B. aalborgi faecal PCR. Potential risk factors for
PCR positivity for the two species also were examined
usingdemographicandhospitaldatarelatingtohealth
and the presence of potential enteric pathogens.
MATERIALS AND METHODS
Ethics approval
The study was conducted with the approval of the Sir
Charles Gardiner Hospital and Murdoch University
Human Ethics Committees.
Stool samples examined
In total, 609 stool samples from 604 individuals were
used for faecal PCR. Of these, 514 samples from rural
patients and migrants had been used in a previous
culture-based study of B. pilosicoli, and further details
of the sources of these samples have been published
[13]. The other 36 samples from the previous study
(all from rural Aboriginal people) were not used
because either they represented multiple samples from
the same individual, or there was insuﬃcient sample
available. The samples used in the current study
comprised 287 from rural WA patients with gastro-
intestinal symptoms, including 142 samples from non-
Aboriginal people and 145 samples from Aboriginal
people; 227 consecutive samples obtained by the WA
Health Department for routine pathogen screening
from healthy recent migrants to WA from developing
countries, including multiple samples from members
of 49 family groups with two or more individuals
tested; and 90 samples from healthy, non-Aboriginal,
non-migrant control individuals living in metro-
politan Perth. The latter individuals worked at, or
were family members of individuals who worked at
the University of Western Australia or Murdoch
University, and all volunteered to provide samples
and personal data. One control individual (C-40) who
was PCR positive for B. aalborgi provided four
additional stool samples at monthly intervals, whilst
another positive individual (C-46) provided a second
sample after 1 month. All samples were stored at
x80 xC until used.
Control strains
B. aalborgi type strain 513AT and B. pilosicoli type
strain P43/6/78T, obtained from the culture collection
at the Reference Centre for Intestinal Spirochaetes at
Murdoch University, were used in the PCRs as posi-
tive and negative controls. The spirochaetes were
propagated anaerobically on non-selective trypticase
soy agar containing 5% (v/v) deﬁbrinated sheep
blood in an atmosphere of 94% H2 and 6% CO2 at
37 xC, for up to 15 days in the case of B. aalborgi.
Viable cells were scraped from the agar and sus-
pended in TE buﬀer (10 mM Tris–HCl, 1 mM EDTA;
pH 8.0) to a concentration of 10
11 cells/ml.
PCR assays
The PCRs used for the detection of B. pilosicoli and
B. aalborgi were the same as described previously for
identiﬁcation of the two organisms in human faeces
[11, 19], with the primers and PCR conditions being
as described by Mikosza and colleagues [3].
DNA extraction from faeces
DNA was extracted from 0.2-g portions of thawed
faeces using the QIAmp DNA Stool Mini Kit,
according to the manufacturer’s instructions (Qiagen
GmbH, Hilden, Germany).
Limits of detection by PCR and culture
The limits of detection of the PCRs were investigated
using human faeces seeded with the two type strains.
Samples were prepared by adding 1 ml of a series of
10-fold dilutions of 1r10
8 to 1r10
3 spirochaetes/ml
of TE, in a blinded fashion, to 1 g of faeces from a
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B. pilosicoli by culture and PCR. The suspensions
were thoroughly vortexed to mix. The seeded samples
were used fresh, and/or stored at x80 xC until being
extracted. The eﬀect of storage on DNA in seeded
samples was tested by comparing the limits of detec-
tion of freshly prepared samples with samples stored
at x80 xC for over 3 months. The limits of detection
of the PCRs also were assessed on their own, using
freshly prepared whole cell suspensions at 10
8–10
1
spirochaetes/ml in TE, of which 2.5 ml was added
directly to reactions. All procedures were performed
in duplicate.
The lower limit of detection of B. pilosicoli in
seeded faeces by culture was assessed by inoculating
selective medium comprising trypticase soy agar
supplemented with 5% deﬁbrinated ovine blood and
400 mg/ml spectinomycin, and incubating the plates at
42 xC for 10 days in an anaerobic jar (94% H2 and
6%CO2) [13]. Spirochaetes recovered from the plates
were identiﬁed on the basis of their morphology, and
their reaction in the 16S rDNA PCR.
Sequencing of PCR products
The sequences of 24 B. pilosicoli and 22 B. aalborgi
16S rRNA gene PCR products were generated with
their respective forward and reverse primers. Samples
for sequencing were selected from all the positive
population groups. Ampliﬁed products were puriﬁed
using a MoBio Ultra Clean PCR clean up DNA
puriﬁcation kit (MoBio Laboratories, Carlsbad, CA,
USA), according to the manufacturer’s instructions.
DNA in the eluent was sequenced using an ABI
PRISM dye terminator cycle sequencing ready reac-
tion kit (ABI Applied Biosystems, Foster City, CA,
USA), according to the manufacturer’s instructions.
The sequence data were aligned and compared with
the sequences of the 16S rRNA genes of B. pilosicoli
strains P43/6/78T (GenBank accession no. U23032)
and WesB (U23034), and B. aalborgi strains 513AT
(Z22781) and W1 (AF200693), using Biomanager
with the ANGIS server (Sydney, NSW, Australia).
The B. aalborgi sequences were compared to diﬀer-
entiating nucleotide positions identiﬁed in previous
phylogenetic analyses of B. aalborgi 16S rDNA
sequences [20, 21].
Demographic and other patient data
Demographic data, and data on the presence of other
enteric pathogens previously have been published for
the non-control patients [13]. The control individuals
from Perth were administered a short questionnaire.
Questions included the individual’s age, gender,
occupation, how long they had lived in Australia,
recent travel history, number of individuals in the
family, health status, recent antibiotic treatments, and
whether they owned pets.
Analysis
The prevalence and 95% conﬁdence interval (CI)
were calculated for each species of intestinal spiro-
chaete overall and for each population group.
Associations between the presence of the spirochaete
species and host and environmental factors were
initially made using a Yates corrected x
2 or a Fisher’s
exact test with one-tailed P value, depending on the
expected population size. Logistic regression analysis
then was performed, again separately for each popu-
lation group and Brachyspira spp. Reasons for clinical
investigation in the Aboriginal and non-Aboriginal
rural patient groups were modelled independently
of risk factors and the presence of other organisms.
Only variables signiﬁcant at Pf0.25 in the univariate
analysis were considered eligible for inclusion in
the logistic regression models. Backward elimination
was used to determine which factors could be
dropped from the model. The likelihood-ratio x
2
statistic was calculated to determine the signiﬁcance
at each step of the model building. The level of
signiﬁcance for a factor to remain in a ﬁnal model was
set at 10%. Statistical comparisons were performed
using Statistix for Windows (Analytical Software,
Tallahassee, FL, USA), Excel 97 (Microsoft Corpor-
ation, Redmond, WA, USA), and Egret for Windows
(version 2.0.3, Cytel Software, Cambridge, MA,
USA).
RESULTS
Limits of detection in seeded faeces
The respective 16S rRNA gene PCRs could detect
1r10
6 cells of B. pilosicoli strain P43/6/78T and
1r10
5 cells of B. aalborgi strain 513AT cells in 200-mg
faecal samples. This corresponded to DNA from
4.2r10
2 and 4.2r10
1 organisms per reaction tube
respectively. Storage of duplicate seeded faecal pre-
parations at x80 xC for over 3 months followed by
DNA extraction did not reduce the level of detection
in either reaction. The lowest concentration of whole
cells in TE which allowed PCR ampliﬁcation was
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cells per reaction for B. aalborgi.
Selective culture of B. pilosicoli was capable of
detecting fewer bacteria than PCR, with isolation
possible from seeded faeces containing 1r10
2 to
2r10
3 colony-forming units (c.f.u.)/g.
Comparison of culture and PCR for detection of
B. pilosicoli in diﬀerent populations
Samples from 514 of the patients that were analysed
for B. pilosicoli by faecal PCR previously had
been analysed by culture [13]. All samples from
the previously identiﬁed culture-positive individuals
(14 Aboriginal and 24 migrant) were positive by PCR
for B. pilosicoli, and an additional 17 samples that had
been culture negative were B. pilosicoli PCR positive.
The new samples comprised seven from Aboriginal
Australians, and 10 from migrants. Using PCR,
the overall prevalence for B. pilosicoli became 14.5%
(21/145) amongst Aboriginal patients, 15% (34/227)
amongst migrants, and remained zero for rural non-
Aboriginal patients and the urban control group. The
sensitivity of PCR for the detection of B. pilosicoli
compared to culture of the organism was 100%,
with a speciﬁcity of 96.8%; the sensitivity of culture
compared to PCR was 69.1%, and the speciﬁcity
was 100%.
Risk factors for B. pilosicoli detection
The detection of additional B. pilosicoli-positive
individuals by PCR altered the signiﬁcance of only a
few risk factors in univariate analysis. In the previous
culture study, B. pilosicoli carriage was signiﬁcantly
increased in Aboriginal children aged 2–5 years, and
in migrants from the Middle East and Africa, with
carriage being signiﬁcantly associated with detection
of faecal protozoa in both groups [13]. Using PCR, in
the Aboriginal group B. pilosicoli carriage was no
longer associated with age group, detection of Giardia
intestinalis, Hymenolepsis nana or protozoa generally.
In the migrant group, carriage was no longer signiﬁ-
cantly associated with country of origin or detection
of any parasite or protozoan. In both population
groups the only new risk factor for B. pilosicoli was
the detection of B. aalborgi, which was more common
in individuals in whom B. pilosicoli was detected
(P<0.001).
In the logistic regression model of risk factors and
organisms associated with B. pilosicoli detection in
Aborigines using faecal PCR, the odds ratio (OR) for
B. pilosicoli detection was 11.8i fB. aalborgi also was
detected (95% CI 2.6–53.3, P=0.001), and was 10
if Blastocystis hominis also was detected (95% CI
1.4–69.6, P=0.02). Amongst migrants, the OR for
B. pilosicoli detection was 21 if B. aalborgi was
detected (95% CI 6.5–68.6, P=0.001), 6.5 when
Iodamoeba bu¨tschlii was detected (95% CI 1.4–29.7,
P=0.015), and 3.4 in individuals who were not of
European origin (95% CI 1.2–9.4, P=0.016).
The logistic regression model created for reasons
for investigation in the Aboriginal population
identiﬁed the odds of B. pilosicoli colonization being
10.9 times greater if ‘possible worms?’ had been
given as a reason for investigation (95% CI 1.6–76.5,
P=0.016), and 5.5 times greater if any of chronic
diarrhoea, failure to thrive (FTT), or being under-
weight were the reasons for the sample submission
(95% CI 1.7–18.1, P=0.005). A stable model could
not be generated for B. pilosicoli in migrants.
Detection of B. aalborgi in control individuals
Five of the 90 (5.6%) control individuals in metro-
politan Perth were positive for B. aalborgi by PCR.
Positive individuals had not taken antibiotics in the
previous month. There was no signiﬁcant diﬀerence in
risk factors for the detection of B. aalborgi in samples
from positive and negative individuals. No P value
was f0.25, therefore the data were not modelled by
logistic regression. The two individuals who had more
than one sample collected at monthly intervals were
both positive at all sampling times.
Detection of B. aalborgi in rural non-Aboriginal
Australians
Eight of the 142 (5.6%) rural non-Aboriginal patients
were positive for B. aalborgi. All positive patients
were aged o18 years, and four were o60 years. Five
colonized patients were from the South West region
of WA. All eight positive patients were suﬀering
from diarrhoea, and this was more frequent than in
B. aalborgi-negative patients (90/134, P=0.048). No
stable logistic regression models could be produced
for this population.
Detection of B. aalborgi in Aboriginal Australians
B. aalborgi was detected in the faeces of 10 out of 145
(6.9%) Aboriginal patients, and both spirochaetes
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B. aalborgi-positive individual was <2 years of age,
whilst two of the individuals colonized by both species
were >60 years of age. Colonization with B. aalborgi
or both spirochaetes together was not aﬀected by
patient gender, geographical location, rainfall distri-
bution, or stool consistency.
Four Aboriginal patients in whom B. aalborgi was
detected were hospitalized, and included two of the
patients in whom B. pilosicoli was detected – a child
<2 years with gastrointestinal symptoms, and an
adult with chronic renal failure, eosinophilia and
chest pain. The other two patients were a 5-year-old
child with eosinophilia and possible worms, in whom
H. nana was detected, and an adult with suspected
Giardia infection.
In logistic regression, the OR for B. aalborgi
detection was 6.6 if the patient was >2 years (95% CI
0.8–52.3), and 5.4 if a parasite was detected (95%
CI 1.3–22.7, P=0.021). A number of reasons for
investigation remained within the model, including
eosinophilia (OR 10.2, 95% CI 0.7–154), suspected
Giardia infection (OR 8.8, 95% CI 0.7–110.5),
chronic diarrhoea, FTT or being underweight
(OR 4.9, 95% CI 0.9–28.6), and eosinophilia, weight
loss, being underweight and possible worms (OR 19.1,
95% CI 3.0–123.1, P=0.002). A stable model could
not be generated for the detection of both organisms
in this population group.
Detection of B. aalborgi in migrants to WA
B. aalborgi was detected in 18 out of 227 (7.9%)
migrant samples, and both spirochaetes were detected
in 12 (5.3%) samples. Carriage of B. aalborgi or both
Brachyspira spp. was not associated with country of
origin. No speciﬁc age group had signiﬁcantly more
individuals with B. aalborgi or both organisms
detected. The only organisms that were associated
with carriage of B. aalborgi were B. pilosicoli
(P<0.001) and any protozoan (P=0.014). No logistic
regression model could be generated for the detection
of B. aalborgi or both organisms.
Twelve of the B. aalborgi-positive individuals
belonging to seven family groups. Single positive
individuals were found in ﬁve families, two positive
individuals came from a family of four, and ﬁve
positive individuals were from a family of six. Both
Brachyspira spp. were detected in samples from
individuals from the latter two families; in two
individuals from the family of four, and in four of the
ﬁve individuals from the family of six. In addition,
both species were detected in two of the ﬁve families
containing single positive individuals.
Sequencing of PCR products
Sequences of 24 B. pilosicoli PCR products from
migrants (M) and Aboriginal Australians (A) were
analysed. A region of 254 bp was sequenced for all
PCR products, and a region of 386 bp was generated
for most products. The main sequence pattern was
100% homologous to the sequence of B. pilosicoli
P43/6/78T in the region equivalent to 243–652 bp of
E. coli 16S rDNA. Minor departures occurred in four
sequences (Table 1).
Sequences from 12 B. aalborgi PCR products
from migrants, Aboriginals and non-Aboriginal (NA)
individuals, and all 10 PCR products from the ﬁve
positive control group individuals (C) were analysed.
A region of 344 bp was sequenced for all products,
with a region of 423 bp assessed for most PCR
products. The sequence of most PCR products was
100% homologous to that of B. aalborgi 513AT in the
region equivalent to 210–629 bp of E. coli 16S rDNA.
Small departures existed in sequences of ﬁve strains,
as shown in Table 2. PCR product sequences from
volunteer C-40 in ﬁve successive months were all
identical in this region, as were the two samples from
control individual C-46.
The B. aalborgi type strain and the strains from
this study with identical sequences corresponded to
B. aalborgi ‘cluster 1’, as identiﬁed in previous
phylogenetic analyses [20, 21]. The diﬀerence in the
sequence of NA-96 at bases 416, 436, 585 and 587
suggested it was a ‘cluster 3’ strain, while strains C-07
and M-197 also demonstrated changes in common
with this cluster. The cytosine replacement at base 214
in NA-96 and C-03 was consistent with them being
either ‘cluster 2’ or ‘cluster 3’ strains.
Table 1. Departures of four B. pilosicoli 16S rDNA
sequences from that of the type strain P43/6/78T in the
region equivalent to base positions 243–652 in E. coli
Sequence Change Base position
A-47 CpT 248
M-61 CpT 307
M-62 CpT 307
A-160 Insertion of a C Between 326 and 327
A, Aboriginal Australian; M, migrant; C, cytosine; T,
thymine.
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Using the faecal PCR methodology, levels of
detection of both Brachyspira spp. from seeded faeces
corresponded to 1r10
5 to 1r10
6 organism/g faeces,
whilst isolation of B. pilosicoli was possible from
faeces containing 1r10
2 to 2r10
3 c.f.u./g. Despite
this diﬀerence in detection level on seeded faeces,
faecal PCR for B. pilosicoli appeared to be at least
as eﬀective as culture in detecting naturally infected
individuals. Not only did the PCR detect all
the culture-positive individuals, it also detected
additional B. pilosicoli-positive people. A possible
explanation could be that the B. pilosicoli cells in
the samples that were PCR positive but culture nega-
tive were non-viable. The PCR methodology for
B. aalborgi detected slightly fewer seeded spirochaetes
than the B. pilosicoli PCR, although the limits of
detection for the two species were broadly compar-
able. Hence, the faecal PCR methodology appeared
eﬀective for determining the comparative prevalence
of the two species.
Sequence analysis of the PCR products conﬁrmed
the speciﬁcity of the reactions, and most sequences
from a given species were identical. For B. pilosicoli,
four PCR products diﬀered at one nucleotide from
the type strain sequence, consistent with the known
heterogeneity in the species [1]. For B. aalborgi, all
except ﬁve strains had an identical sequence to the
cultured strains 513AT and W1, which corresponded
to cluster 1 described by Pettersson et al. [20].
The other ﬁve strains, representing samples from 29%
(5/17) of the individuals from whom product was
sequenced, may have been from cluster 2 or 3.
Currently, the comparative epidemiology and patho-
genic potential of members of these diﬀerent clusters
is unclear.
The use of PCR for detection of B. pilosicoli added
relatively little to the conclusions derived from a pre-
vious investigation in WA based on culture of these
samples [13]. Again, colonization was restricted to the
Aboriginal and migrant groups, but with the apparent
prevalence of faecal shedding increased to levels
more consistent with that previously described in
Aboriginal children in a remote rural community in
WA (33%) [12], and to those of villagers in Papua
New Guinea (23%) [9], India (25%) [11], and Bali,
Indonesia (12%) [10]. Apart from the presence of
B. aalborgi, which was signiﬁcantly associated with
the presence of B. pilosicoli in both population
groups, and in the previous study from India [11], the
new analysis did not strengthen the identiﬁcation of
signiﬁcant risk factors. It was unfortunate that data
were not available on water supply or water quality,
as in previous studies in both India and Bali the use of
untreated well water was associated with increased
B. pilosicoli carriage [10, 11]. Diﬀerences in water
quality might have helped explain the diﬀerent
prevalence observed amongst population groups in
this study.
Results for the Aboriginal patient group provided
some indirect evidence that B. pilosicoli can have a
pathogenic role. Four of the newly identiﬁed patients
were in hospital at the time of sampling, and two were
infants with gastrointestinal symptoms but without
other pathogens being detected. Logistic regression
identiﬁed diagnoses of ‘possible worms’, and chronic
diarrhoea, FFT and being underweight as being sig-
niﬁcantly associated with the presence of B. pilosicoli.
Chronic diarrhoea is a symptom that has been associ-
ated with IS in a number of human studies [22–24].
A major new ﬁnding in this study was the identiﬁ-
cation of B. aalborgi in almost equal proportions in
the faeces of the four population groups examined
(5.6–7.9%). This rate was similar to the 6% found
in villagers in India [11]. Furthermore, carriage in
migrants was not aﬀected by their country of origin.
These data suggest that B. aalborgi is distributed at
a similar prevalence in many human populations
throughout the world. Its distribution was quite
diﬀerent from that of B. pilosicoli, which was found
only in Aboriginal and migrant individuals, and
which occurred at a higher prevalence (y15%).
Attempts to identify speciﬁc risk factors that might
explain the diﬀerent distributions of the two related
Table 2. Departures of ﬁve B. aalborgi 16S rDNA
sequences from that of the type strain 513T in the
region equivalent to base positions 210–629 in E. coli
Sequence Change Base position
NA-96 TpG 214
NA-96 GpT 416
NA-96 TpC 436
NA-96 TpG 585
NA-96 TpG 587
C-07 GpT 416
C-07 TpC 436
C-03 TpC 214
M-197 GpT 416
NA-131 Insertion of a T Between 530 and 531
NA, Non-Aboriginal; C, control group; M, migrant; G,
guanine; C, cytosine; T, thymine.
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Generally there was a lack of consistency between the
populations in the risk factors that were associated
with B. aalborgi detection, despite the populations
having a similar prevalence. In part, this inconsistency
may have been due to the small number of positive
individuals overall, as well as to the lack of uniformity
in the criteria used for sample selection from the
diﬀerent groups.
The pathogenic signiﬁcance of B. aalborgi could
not be resolved in this investigation. First, B. aalborgi
was detected in similar proportions in samples from
ill (rural) and healthy individuals. Detection was
not associated with the presence of gastrointestinal
symptoms in control individuals, nor with loose or
wet stool consistency in any population group. In
addition, detection of B. aalborgi was signiﬁcantly
associated with diﬀerent reasons for investigation in
the two ill rural population groups. Detection of
B. aalborgi was associated with diarrhoea in rural
non-Aboriginals, whilst amongst Aboriginals it was
signiﬁcantly associated with a number of other
reasons for investigation, includingchronic diarrhoea,
eosinophilia, weight loss, being underweight and sus-
pected worms. It was not know whether B. aalborgi
was a cause of these symptoms, or was excreted as a
result of symptoms arising for some other reason.
Consistent with earlier suggestions [25], the similar
prevalence of B. aalborgi in all population groups
suggests that it could be a commensal. This possibility
is supported by the ﬁnding that control individual
C-40 was colonized by a strain of B. aalborgi over
a period of at least 5 months, whilst apparently
remaining healthy. On the other hand, B. aalborgi was
found in rural patients with gastrointestinal symp-
toms in whom no other pathogenic microorganisms
were detected. A similar situation has been reported
in other investigations [3, 26, 27]. It is possible that
diﬀerent strains or ‘groups’ [20] of B. aalborgi may
vary in their virulence, or that the extent or site of
colonization may inﬂuence the clinical outcome. To
investigate these possibilities, it would be useful to
develop animal models in which to test the virulence
of diﬀerent B. aalborgi isolates.
Putting the available data together, we hypothesize
that the slow growing and fastidious B. aalborgi is
a human-adapted species, with generally low patho-
genic potential. It may be present in low or un-
detectable numbers in many individuals throughout
the world, although it can overgrow and cause clinical
signs in some people under some circumstances.
As with other members of the intestinal commensal
microbiota [28], B. aalborgi may induce an immune
tolerance that allows it to persist attached to or in
close proximity to the colorectal mucosa for extended
periods. The spirochaete is probably transmitted by
the faecal–oral route, but also there is potential for
spread by ingestion of water or food that is contami-
nated by human faeces. In contrast, B. pilosicoli is not
speciﬁcally human adapted, and has greater patho-
genic potential in humans (and animals). Humans are
infected by indirect routes such as exposure to water
contaminated by the faeces of animals, birds or
infected humans, as well as by faecal–oral cycling
amongst human groups living in close proximity in
conditions of poor hygiene. In this respect the trans-
mission resembles that of many intestinal protozoa.
In those population groups where exposure to
B. pilosicoli occurs, prior colonization by B. aalborgi
is a risk factor for colonization, perhaps because of
a pre-existing tolerance that occurs to the related
spirochaete. This situation tends to limit the gener-
ation of protective immune responses against
B. pilosicoli, which in turn enhances its ability to
colonize. Clearly, these hypotheses require further
experimental investigation to determine their validity.
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